UDCA for Symptomatic Gallstone Disease

计划入组 180 人 · 首次发布于 2005 年 9 月 12 日

Comparative Bioavailability Study of UDCA

计划入组 50 人 · 首次发布于 2015 年 3 月 11 日

Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA

首次发布于 2016 年 11 月 17 日

HDAC6i-UDCA conjugates

nor-NOHA

C₅H₁₂N₄O₃

NCX-1000

C₃₈H₅₅NO₁₀

Tannhelsetjenestens Kompetansesenter for Nord-Norge

Norway

Vor Biopharma

United States

Not Applicable

Mauritius

Shilpa Medicare's Novel NAFLD Treatment Receives CDSCO Approval Following Successful Phase 3 Trial

GLORIOUS Trial: Exenatide and Restrictive Oxygenation Fail to Improve Outcomes in Cardiac Surgery

Aethlon and North Immunology Merge to Advance IL-13 x IL-18 Bispecific Antibody NOR-101 for Atopic Dermatitis